Skip to main content
SpringerLink
Log in

L 647339: results from open trials indicate that this D2-receptor agonist is a promising agent in Parkinson's disease

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

L 647339: results from open trials indicate that this D2-receptor agonist is a promising agent in Parkinson's disease. Inpharma Wkly. 660, 5 (1988). https://doi.org/10.1007/BF03309089

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309089

Keywords

Search

Navigation